CoChat

Efficacy, Safety, and Tolerability of Sertraline in Patients with Late‐Life Depression and Comorbid Medical Illness

Sheikh, Javaid I., Cassidy, Erin L., Doraiswamy, P. Murali, Salomon, Ronald M., Hornig, Mady, Holland, Peter J., Mandel, Francine S., Clary, Cathryn M., Burt, Tal · 2004 · Journal of the American Geriatrics Society
Cited by 91

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Objectives: To report on the efficacy, safety, and tolerability of sertraline in the treatment of elderly depres‐sed patients with and without comorbid medical illness. Setting: Multicenter. Design: Randomized, double‐blind, placebo‐controlled study. Participants: A total of 752 patients aged 60 and older with diagnosis of major depressive disorder according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition , diagnosis. Measurements: Outcome measures included the 17‐item Hamilton Depression Scale (HAMD); the Clinical Global Depression—Severity/Improvement (CGI‐S/CGI‐I); efficacy and safety/adverse event assessments; Quality of Life, Enjoyment, and Satisfaction Questionnaire; and the Medical Outcomes Study 36‐Item Short‐Form Health Status Survey. Results: In the overall sample, sertraline was superior to placebo on all three primary outcome measures, HAMD, and overall clinical severity and change (CGI‐S/CGI‐I). Furthermore, therapeutic response to sertraline was comparable in those with or without medical comorbidity, and there were no treatment‐by–comorbidity group interactions. Sertraline was also associated with a faster time to response than placebo in the comorbid group ( P <.006). Sertraline‐treated patients in the comorbid group had similar adverse events and discontinuations when compared to those in the noncomorbid group. Conclusion: Sertraline was efficacious in reducing depressive symptomatology, regardless of the presence of comorbid medical illness. Sertraline was safe and well tolerated by patients with or without medical illness.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1532-5415.2004.52015.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 25

  1. 10.1001/jama.286.13.1621 · DOI · Paper page
  2. 10.1001/archpsyc.55.7.580 · DOI · Paper page
  3. 10.1097/00004850-199707000-00006 · DOI · Paper page
  4. Wassertheil‐Smoller S, 1996, Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly), Arch Intern Med, 156, 553, 10.1001/archinte.1996.00440050111012 · DOI · Paper page
  5. 10.1161/01.CIR.91.4.999 · DOI · Paper page
  6. 10.1161/hc0902.104707 · DOI · Paper page
  7. 10.1001/archpsyc.58.3.221 · DOI · Paper page
  8. De Groot M, 2001, Association of depression and diabetes complications, A meta-analysis, 63, 619
  9. 10.1097/00019442-200111000-00009 · DOI
  10. Nelson JC, 1999, Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease, Am J Psychiatry, 156, 1024, 10.1176/ajp.156.7.1024 · DOI · Paper page
  11. 10.1002/(SICI)1520-6394(1998)8:4<147::AID-DA3>3.0.CO;2-F · DOI · Paper page
  12. 10.1097/00019442-200005000-00009 · DOI · Paper page
  13. 10.1111/j.1532-5415.1996.tb01373.x · DOI · Paper page
  14. 10.1002/(SICI)1099-1166(199712)12:12<1189::AID-GPS715>3.0.CO;2-Z · DOI · Paper page
  15. Krishnan KR, 2001, Clinical and treatment response characteristics of late‐life depression associated with vascular disease, A pooled analysis of two multicenter trials with sertraline, 25, 347
  16. 10.1111/j.2044-8341.1959.tb00467.x · DOI · Paper page
  17. Guy W., 1976, ECDEU Assessment Manual for Psychopharmacology (U.S. Department of Health, Education and Welfare Publication no. (ADM) 76–338)
  18. Endicott J, 1993, Quality of life enjoyment and satisfaction questionnaire, A new measure, 29, 321
  19. 10.1093/ageing/23.3.182 · DOI · Paper page
  20. 10.4088/JCP.v59n0406 · DOI · Paper page
  21. Preskorn SH., 1998, Debate resolved, There are differential effects of serotonin selective reuptake inhibitors on cytochrome P450 enzymes, 12, S89
  22. 10.2165/00002512-200219040-00004 · DOI
  23. 10.1017/S1041610295002407 · DOI · Paper page
  24. Gill D, 2000, Antidepressants for depression in medical illness, Cochrane Database Syst Rev, 2, CD001312
  25. 10.1097/00019442-200209000-00013 · DOI

Cited by

See all 91

Metadata

Authors
Sheikh, J. I., Cassidy, E. L., Doraiswamy, P. M., Salomon, R. M., Hornig, M., Holland, P. J., Mandel, F. S., Clary, C. M., & Burt, T.
Venue
Journal of the American Geriatrics Society
Publisher
Wiley
Published
2003-12-24
Volume
52
Issue
1
Pages
86-92
ISSN
  • 0002-8614 (ISSN-L)
  • 1532-5415
OpenAlex
W1503668654
Cited by
91
References
4
FWCI
4.39
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy, Safety, and Tolerability of Sertraline in Patients with Late‐Life Depression and Comorbid Medical Illness. https://app.cochat.ai/papers/10.1111/j.1532-5415.2004.52015.x
The paper
Sheikh, J. I., Cassidy, E. L., Doraiswamy, P. M., Salomon, R. M., Hornig, M., Holland, P. J., Mandel, F. S., Clary, C. M., & Burt, T. (2004). Efficacy, Safety, and Tolerability of Sertraline in Patients with Late‐Life Depression and Comorbid Medical Illness. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2004.52015.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.